United States · Growth startup
Funding summaryUpdated 26 Oct 2026
$97Mraised across 6 rounds since 2007, from 6 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
Reported by celatorpharma.comSEC filing: $39M sold, first sale Aug 2012
No investor was named in the report.
Reported by sec.govSEC filing: $2.6M sold, first sale Dec 2011
BDC Capital
Domain Associates
TL Ventures
Quaker Partners
Thomas, McNerney & PartnersReported by celatorpharma.comSEC filing: $15M sold, first sale Aug 2010
No investor was named in the report.
Reported by sec.govSEC filing: $2.5M sold, first sale May 2010
From a historical funding record
From a historical funding record
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
BDC CapitalDomain AssociatesGrowthWorksTL VenturesQuaker PartnersVentures WestThomas, McNerney & Partners
ROTH Capital Partners
Valence Life SciencesVenture west Managment groupMissing a round, or an investor who was in one? Tell us.
Celator Pharmaceuticals's investors include BDC Capital, Domain Associates, GrowthWorks, TL Ventures and Quaker Partners, and 5 more on record.
Celator Pharmaceuticals has raised $97M across 6 rounds since 2007.
Celator Pharmaceuticals's most recent round was a Growth of $39M in Apr 2013.
Its most recent round, $39M in Apr 2013, is also its largest on record.
Celator Pharmaceuticals's first round on record, in Aug 2007, was backed by BDC Capital, Domain Associates and GrowthWorks and 3 others.
Celator Pharmaceuticals's latest named round is a Growth, in Apr 2013.
Celator Pharmaceuticals is based in the United States.
In the same sector, and raised in the last eighteen months.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.
United States · 
